About
Madeleine Therapeutics is a French biotechnology company developing first-in-class antibody therapeutics targeting a novel cytokine pathway for autoimmune and inflammatory diseases.
Explore Madeleine Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.